In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom
In main results from the phase 3 trial, as well as those from an open-label extension, the investigational drug also proved its ability to positively influence several noninvasive efficacy outcomes.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 30, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Irritable Bowel Syndrome Therapy Removed From Market (Again) Irritable Bowel Syndrome Therapy Removed From Market (Again)
Zelnorm, a short-term IBS-C treatment, has been removed from the market. The drug manufacturer cited ' business concerns. 'News Alerts (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 30, 2022 Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news

Prevalence of CRC Screening Remains Low in Those Aged 50 to 54
Increase in screening differed by age, with 19.4 percent increase for those aged 50 to 54 and 31.6 percent increase for those aged 70 to 75 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 30, 2022 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Kissing Can Spread Norovirus; Mood Tied to Bowel Prep Symptoms; Anti-TNF & Psoriasis
(MedPage Today) -- NIH scientists discovered that enteric viruses such as norovirus and rotavirus can replicate and spread through saliva, making talking, coughing, sneezing, and kissing potential routes of transmission. (Nature) As of the latest... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 30, 2022 Category: Gastroenterology Source Type: news

Consensus Current Procedural Terminology Code Definition of Source Control for Sepsis
Conclusions: Using modified Delphi methodology, we created and validated CPT codes identifying source control procedures, providing a framework for evaluation of the surgical care of patients with sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 30, 2022 Category: Consumer Health News Source Type: news

JCAHO Standards Not Always Supported by High - Quality Evidence
Of 20 actionable standards from The Joint Commission, six completely supported by references, six partly supported (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 29, 2022 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

How Changing Your Diet Could Have a Major Impact on Managing Lupus Symptoms
After Jewell Singletary was diagnosed with lupus, she developed rheumatoid arthritis as well—a common pairing, since both are autoimmune conditions—and had to use a cane to navigate her college campus. When she graduated, the now 38-year-old New Jersey resident decided to be more focused on supporting her health, in an effort to maintain her mobility as she began her career. She started in the kitchen. First to be tossed were sugary drinks, fried foods, and highly processed options, she says. Once she eliminated them, it didn’t take long before she could discard one more important item: her cane. [time-br...
Source: TIME: Health - June 29, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Diet & Nutrition freelance healthscienceclimate Source Type: news

Predicting Post-Surgery T2D Remission; Infertility & Strokes; Cold Thwarts Obesity?
(MedPage Today) -- Testing blood levels of ceramides after Roux-en-Y gastric bypass surgery helped to predict exactly which patients may achieve type 2 diabetes remission within the 2 years after surgery. "[These findings] reveal a new tool in... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 29, 2022 Category: Endocrinology Source Type: news

Scientists pinpoint new brain target for antinausea drugs
Whether we’ve got the flu or have had too much to drink, most of us have experienced nausea. Unlike other universal sensations such as hunger and thirst, however, scientists still don’t understand the biology behind the feeling—or how to stop it. A new study in mice identifies a possible key player: specialized brain cells that communicate with the gut to turn off the feeling of nausea. It’s an “elegant” study, says Nancy Thornberry, CEO of Kallyope, a biotechnology company focused on the interplay between the gut and the brain. Further research is needed to translate the finding into antinausea therapies...
Source: ScienceNOW - June 29, 2022 Category: Science Source Type: news

CRC Screening Disparities Greatest Among Those Under 55 CRC Screening Disparities Greatest Among Those Under 55
Despite improvements in the proportion of people screened since 2000, disparities remain particularly high for younger adults and those with fewer resources.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 29, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Targets for the Pharmacologic Management of Celiac Disease Targets for the Pharmacologic Management of Celiac Disease
Several promising therapeutic agents are currently under investigation for the treatment of celiac disease. Review the evidence supporting existing and future drug targets in this paper.Alimentary Pharmacology & Therapeutics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 29, 2022 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

'A New Hope' for Rare, Deadly Liver Disease
(MedPage Today) -- An investigational, potential first-in-class RNA interference (RNAi) therapy showed promise for treating patients with liver disease associated with alpha1-antitrypsin (AAT) deficiency, results of a phase II trial suggested... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 28, 2022 Category: Gastroenterology Source Type: news

Baclofen Shows Limited Role in GERD Baclofen Shows Limited Role in GERD
The drug showed benefit in PPI refractory symptoms for patients with non-acid reflux.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 28, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Novel Liver-Targeting Drug Offers Hope for AAT Deficiency Novel Liver-Targeting Drug Offers Hope for AAT Deficiency
The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 28, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Efficacy and Safety of DAA Therapy for HCV in Elderly Patients Efficacy and Safety of DAA Therapy for HCV in Elderly Patients
Is the efficacy of direct-acting antivirals, as measured by SVR, significantly different in patients 65 and older compared to younger patients?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news